Enfusion Stock Odds of Future Stock Price Finishing Over 8.58
| ENFN Stock | USD 9.00 0.09 1.01% |
Enfusion |
Enfusion Target Price Odds to finish over 8.58
The tendency of Enfusion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 8.58 in 90 days |
| 9.00 | 90 days | 8.58 | about 55.68 |
Based on a normal probability distribution, the odds of Enfusion to stay above $ 8.58 in 90 days from now is about 55.68 (This Enfusion probability density function shows the probability of Enfusion Stock to fall within a particular range of prices over 90 days) . Probability of Enfusion price to stay between $ 8.58 and its current price of $9.0 at the end of the 90-day period is about 28.49 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.07 suggesting Enfusion market returns are highly reactive to returns on the market. As the market goes up or down, Enfusion is expected to follow. Additionally Enfusion has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Enfusion Price Density |
| Price |
Predictive Modules for Enfusion
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enfusion. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enfusion's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enfusion Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Enfusion is not an exception. The market had few large corrections towards the Enfusion's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enfusion, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enfusion within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | 1.07 | |
σ | Overall volatility | 0.56 | |
Ir | Information ratio | -0.0075 |
Enfusion Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enfusion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enfusion can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Enfusion is unlikely to experience financial distress in the next 2 years | |
| Enfusion has a very strong financial position based on the latest SEC filings | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Enfusion Announces Date of Third Quarter 2024 Results |
Enfusion Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enfusion Stock often depends not only on the future outlook of the current and potential Enfusion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enfusion's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 129.4 M | |
| Cash And Short Term Investments | 35.6 M |
Enfusion Technical Analysis
Enfusion's future price can be derived by breaking down and analyzing its technical indicators over time. Enfusion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enfusion. In general, you should focus on analyzing Enfusion Stock price patterns and their correlations with different microeconomic environments and drivers.
Enfusion Predictive Forecast Models
Enfusion's time-series forecasting models is one of many Enfusion's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enfusion's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Enfusion
Checking the ongoing alerts about Enfusion for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enfusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Enfusion is unlikely to experience financial distress in the next 2 years | |
| Enfusion has a very strong financial position based on the latest SEC filings | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Enfusion Announces Date of Third Quarter 2024 Results |
Additional Information and Resources on Investing in Enfusion Stock
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:Check out Enfusion Backtesting, Enfusion Valuation, Enfusion Correlation, Enfusion Hype Analysis, Enfusion Volatility, Enfusion History as well as Enfusion Performance. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.572 | Earnings Share 0.04 | Revenue Per Share 2.11 | Quarterly Revenue Growth 0.158 | Return On Assets 0.0374 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.